Moxydari CV 625 Tablet
Images are for reference. Actual packaging may vary.
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Amoxycillin inhibits the synthesis of peptidoglycan in bacterial cell walls, leading to cell lysis and death.
Medical applications
The Moxydari CV 625 Tablet is a combined antibacterial medication containing Amoxycillin 500mg and Clavulanic Acid 125mg. This combination is designed to treat a broad spectrum of bacterial infections, including those that are resistant to amoxycillin alone. Amoxycillin, a semisynthetic penicillin, inhibits bacterial cell wall synthesis, while Clavulanic Acid acts as a beta-lactamase inhibitor, protecting amoxycillin from enzymatic degradation by bacterial enzymes.
This dual-action formula enhances the effectiveness of the treatment and reduces the potential for bacterial resistance. The Moxydari CV 625 Tablet is indicated for various respiratory, genitourinary, skin, and soft tissue infections, as well as dental infections. It should be administered under the supervision of a healthcare professional, and the dose and duration of treatment should be individualized based on the patient's specific condition and response to therapy.
How can I give Moxydari CV 625 Tablet to my child? Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Moxydari CV 625 Tablet is to be taken with food.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Moxydari CV 625 Tablet should be used with caution in patients with liver disease. Dose adjustment of Moxydari CV 625 Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended while you are taking this medicine
Regular Checkup
Moxydari CV 625 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moxydari CV 625 Tablet may be needed. Please consult your doctor. Use of this medicine is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Moxydari CV 625 Tablet







